DE69716485T2 - Taxol enthaltende pharmazeutische injektionslösung - Google Patents

Taxol enthaltende pharmazeutische injektionslösung

Info

Publication number
DE69716485T2
DE69716485T2 DE69716485T DE69716485T DE69716485T2 DE 69716485 T2 DE69716485 T2 DE 69716485T2 DE 69716485 T DE69716485 T DE 69716485T DE 69716485 T DE69716485 T DE 69716485T DE 69716485 T2 DE69716485 T2 DE 69716485T2
Authority
DE
Germany
Prior art keywords
taxol
injection solution
containing pharmaceutical
tromethamine
pharmaceutical injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69716485T
Other languages
English (en)
Other versions
DE69716485D1 (de
Inventor
Man Woo Han
Nam Doo Hong
Jae Kuk Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69716485D1 publication Critical patent/DE69716485D1/de
Application granted granted Critical
Publication of DE69716485T2 publication Critical patent/DE69716485T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
DE69716485T 1997-05-30 1997-05-30 Taxol enthaltende pharmazeutische injektionslösung Expired - Lifetime DE69716485T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1997/000623 WO1998053810A1 (en) 1997-05-30 1997-05-30 Pharmaceutical injection solution containing taxol

Publications (2)

Publication Number Publication Date
DE69716485D1 DE69716485D1 (de) 2002-11-21
DE69716485T2 true DE69716485T2 (de) 2003-04-10

Family

ID=11004572

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716485T Expired - Lifetime DE69716485T2 (de) 1997-05-30 1997-05-30 Taxol enthaltende pharmazeutische injektionslösung

Country Status (4)

Country Link
EP (1) EP0998279B1 (de)
AT (1) ATE226070T1 (de)
DE (1) DE69716485T2 (de)
WO (1) WO1998053810A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.

Also Published As

Publication number Publication date
DE69716485D1 (de) 2002-11-21
ATE226070T1 (de) 2002-11-15
EP0998279B1 (de) 2002-10-16
WO1998053810A1 (en) 1998-12-03
EP0998279A1 (de) 2000-05-10

Similar Documents

Publication Publication Date Title
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
CY2562B1 (en) Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
ID22763A (id) Komposisi penstabil tibolon
SE9301877D0 (sv) In situ gel for therapeutic use
DE69716485D1 (de) Taxol enthaltende pharmazeutische injektionslösung
KR910007523A (ko) 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올
KR910009267A (ko) 우울증의 치료방법
KR970073583A (ko) 탁속을 함유한 주사용 약제 조성물
KR960003717A (ko) 항암제에 의해 유발되는 말초신경병의 예방에 유용한 의약의 제조를 위한 엘리프로딜 및 그 거울상이성질체의 이용
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
KR910002434A (ko) 레티노이드의 용도
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
KR920019356A (ko) 약제학적 조성물 및 그 제조방법
KR880000094A (ko) 위염치료제
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
KR900000081A (ko) 트리암테렌의 약학적 액제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition